buflomedil has been researched along with Chronic Disease in 11 studies
buflomedil: RN given refers to parent cpd; synonym LL 1656 refers to HCl; structure
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
Excerpt | Relevance | Reference |
---|---|---|
"Buflomedil chlorhydrate is a newly synthesized molecule with a notable effect of vasodilatation even on cerebral blood vessels." | 6.66 | [Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride]. ( Ciuffetti, G; Lombardini, R; Mercuri, M; Palazzetti, D; Parnetti, L; Rizzo, MT, 1989) |
"Buflomedil chlorhydrate is a newly synthesized molecule with a notable effect of vasodilatation even on cerebral blood vessels." | 2.66 | [Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride]. ( Ciuffetti, G; Lombardini, R; Mercuri, M; Palazzetti, D; Parnetti, L; Rizzo, MT, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (72.73) | 18.7374 |
1990's | 3 (27.27) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cajozzo, A | 1 |
Abbadessa, V | 1 |
Musso, M | 1 |
Iannitto, E | 1 |
Dubourg, A | 1 |
Scamuffa, RF | 1 |
Sunder-Plassmann, L | 1 |
Messmer, K | 1 |
Becker, HM | 1 |
Marci, M | 1 |
Albiani, B | 1 |
Ricci, M | 1 |
Russo, F | 1 |
Paterna, S | 1 |
Martino, S | 1 |
Ingurgio, NC | 1 |
Arrostuto, A | 1 |
Correo, S | 1 |
Licata, G | 1 |
Van den Brande, P | 1 |
Maurel, A | 1 |
Lombardini, R | 2 |
Ciuffetti, G | 2 |
Paltriccia, R | 1 |
Scarponi, AM | 1 |
Savastano, V | 1 |
Palazzetti, D | 2 |
Mercuri, M | 2 |
Parnetti, L | 2 |
Rizzo, MT | 1 |
Briguglio, F | 1 |
Di Marco, V | 1 |
Circosta, C | 1 |
Padovano, I | 1 |
Ragusa, S | 1 |
Saija, A | 1 |
Briguglio, E | 1 |
Montemurro, NE | 1 |
Damiano, M | 1 |
Mozzi, E | 1 |
Chiurazzi, D | 1 |
Spinola, A | 1 |
Annoni, F | 1 |
Germiniani, R | 1 |
2 reviews available for buflomedil and Chronic Disease
Article | Year |
---|---|
An experimental overview of a new vasoactive drug: buflomedil HCl.
Topics: Animals; Cerebrovascular Disorders; Chronic Disease; Coronary Disease; Dogs; Hemodynamics; Humans; I | 1981 |
[Treatment of chronic obliterative arteriopathy of the legs in the second Fontaine's stage. Personal experience with a buflomedil-pentoxifylline-defibrotide combination].
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Chronic Disease; Drug Therapy, Combination; Fe | 1995 |
4 trials available for buflomedil and Chronic Disease
Article | Year |
---|---|
[Effect of buflomedil on the behavior of platelet aggregation and its clinical evaluation in elderly patients with chronic cerebrovascular insufficiency].
Topics: Aged; Chronic Disease; Clinical Trials as Topic; Female; Humans; Intracranial Arteriosclerosis; Male | 1983 |
[The effects of terazosin hydrochloride and buflomedil in patients with hemicrania without aura].
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Chronic Disease; Drug Therapy, Combination; Female; | 1994 |
A placebo-controlled study of the effects of intravenous Buflomedil on foot skin microcirculation in patients with severe intermittent claudication.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Chronic Disease; Dose-Response Relationship, D | 1998 |
[Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride].
Topics: Aged; Cerebrovascular Disorders; Chronic Disease; Clinical Trials as Topic; Erythrocyte Deformabilit | 1989 |
5 other studies available for buflomedil and Chronic Disease
Article | Year |
---|---|
Tissue pO2 and transcutaneous pO2 as guidelines in experimental and clinical drug evaluation.
Topics: Animals; Arterial Occlusive Diseases; Arteriosclerosis; Chronic Disease; Collateral Circulation; Dog | 1981 |
[Effects of buflomedil hydrochloride on the rheological properties of the blood in chronic cerebrovascular diseases].
Topics: Aged; Blood Viscosity; Cerebrovascular Disorders; Chronic Disease; Erythrocyte Deformability; Female | 1989 |
Metabolic effects of buflomedil hydrochloride.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Adenylyl Cyclases; Adult; Aged; Arterial Occlusive D | 1985 |
[Treatment of circulatory insufficiency with buflomedil chlorhydrate in chronic hemodialysis patients].
Topics: Adult; Aged; Chronic Disease; Female; Humans; Male; Middle Aged; Pyrrolidines; Renal Dialysis; Uremi | 1986 |
Effects of buflomedil in a group of patients with chronic peripheral arterial diseases. Clinical and hemorheological evaluation.
Topics: Aged; Arterial Occlusive Diseases; Blood Flow Velocity; Blood Viscosity; Chronic Disease; Female; Hu | 1985 |